Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/23/2025

End-of-Life Care Management

Core Components of End-of-Life Care

  • The American College of Physicians recommends regular and periodic assessment of pain, dyspnea, and depression for all patients with serious illness at the end of life 1
  • Pain management should include NSAIDs, opioids, and bisphosphonates for cancer patients, with bisphosphonates being specifically effective for bone pain in breast cancer and myeloma patients 3, 4
  • Dyspnea management should include opioids for patients with unrelieved dyspnea in cancer and cardiopulmonary disease, oxygen therapy for short-term relief of hypoxemia, and β-agonists for treating dyspnea in chronic obstructive pulmonary disease 2, 3, 5
  • Depression management should include tricyclic antidepressants, selective serotonin reuptake inhibitors, or psychosocial interventions for cancer patients, with regular assessment and management of depression symptoms in patients with serious chronic diseases 3, 4

Palliative Sedation

  • Palliative sedation may be considered for refractory symptoms at the end of life, with medications for symptom palliation continued unless ineffective or causing distressing side effects 6, 7
  • For respite sedation, the lowest effective dose of sedative agent should be administered, with routine physiological parameters monitored 7

Essential Medications

  • Morphine is an essential drug for quality care of the dying, used for pain and dyspnea management 5

Advance Care Planning

  • Advance care planning, including completion of advance directives, should occur for all patients with serious illness, addressing specific elements such as surrogate decision makers, resuscitation and emergency treatment preferences, and specific issues related to the patient's clinical course 3, 8
  • Care plans should be reassessed when significant clinical changes occur, with care directives discussed with the patient, family members, and healthcare providers 3, 7

Family and Caregiver Support

  • Family members and friends should be allowed and encouraged to be with the patient, reassured that other methods have been sufficiently tried, and kept informed about the patient's well-being and what to expect 7
  • The care team should provide supportive care to family members, including listening to concerns and attention to grief, with regular information updates about the patient's condition and opportunity to meet after the patient's death to express grief and discuss any concerns 7

Special Considerations

  • For patients at home and at risk of catastrophic events, sedating medications should be prepared in advance with a clear plan for emergency administration, with consideration of inpatient care if family members feel unable to administer emergency medications 7
  • End-of-life decisions should be discussed in a multidisciplinary approach, considering the patient's directives, family feelings, and representatives' desires, with the palliative care team involved as soon as possible for managing severely injured elderly patients at end-of-life status 3, 9

REFERENCES